Ebba Bergman, Lars Rylander, Christian Lindh, Jesse D Thacher
{"title":"Vitamin D deficiency in early pregnancy and the risk of developing cerebral palsy: A case-control study.","authors":"Ebba Bergman, Lars Rylander, Christian Lindh, Jesse D Thacher","doi":"10.1111/dmcn.70573","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To investigate whether maternal deficiency of vitamin D in early pregnancy increases the risk of cerebral palsy (CP) in offspring.</p><p><strong>Method: </strong>This registry and biobank-based case-control study consisted of mother-child pairs from Scania, Sweden. Cases (n = 322) were identified from a nationwide CP-register born between 1995 and 2014. Random population controls (n = 343) and preterm controls (n = 258) were identified from a birth registry. Serum samples taken during pregnancy were obtained from a biobank and 25(OH)D<sub>3</sub> concentrations were categorized into three groups: sufficient (≥ 75 nmol/L), insufficient (50-74.9 nmol/L), and deficient (< 50 nmol/L). Logistic regression was used to investigate associations between 25(OH)D<sub>3</sub> concentrations and CP. Separate analyses were completed among children born preterm and at term, as well as for subtypes of CP.</p><p><strong>Results: </strong>Deficiency of 25(OH)D<sub>3</sub> was not associated with a significantly higher risk of CP compared with sufficient values in the studied groups of all children (odds ratio [OR]: 1.34; 95% confidence interval [CI]: 0.86-2.10), children born at term (OR: 1.48; 95% CI: 0.89-2.44), and children born preterm (OR: 0.74; 95% CI: 0.37-1.46).</p><p><strong>Interpretation: </strong>No apparent association between 25(OH)D<sub>3</sub> and CP was observed; however, the relatively small sample size and reliance on a single vitamin D measurement may have limited the detection of modest effects.</p>","PeriodicalId":50587,"journal":{"name":"Developmental Medicine and Child Neurology","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Developmental Medicine and Child Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dmcn.70573","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Aim: To investigate whether maternal deficiency of vitamin D in early pregnancy increases the risk of cerebral palsy (CP) in offspring.
Method: This registry and biobank-based case-control study consisted of mother-child pairs from Scania, Sweden. Cases (n = 322) were identified from a nationwide CP-register born between 1995 and 2014. Random population controls (n = 343) and preterm controls (n = 258) were identified from a birth registry. Serum samples taken during pregnancy were obtained from a biobank and 25(OH)D3 concentrations were categorized into three groups: sufficient (≥ 75 nmol/L), insufficient (50-74.9 nmol/L), and deficient (< 50 nmol/L). Logistic regression was used to investigate associations between 25(OH)D3 concentrations and CP. Separate analyses were completed among children born preterm and at term, as well as for subtypes of CP.
Results: Deficiency of 25(OH)D3 was not associated with a significantly higher risk of CP compared with sufficient values in the studied groups of all children (odds ratio [OR]: 1.34; 95% confidence interval [CI]: 0.86-2.10), children born at term (OR: 1.48; 95% CI: 0.89-2.44), and children born preterm (OR: 0.74; 95% CI: 0.37-1.46).
Interpretation: No apparent association between 25(OH)D3 and CP was observed; however, the relatively small sample size and reliance on a single vitamin D measurement may have limited the detection of modest effects.
期刊介绍:
Wiley-Blackwell is pleased to publish Developmental Medicine & Child Neurology (DMCN), a Mac Keith Press publication and official journal of the American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) and the British Paediatric Neurology Association (BPNA).
For over 50 years, DMCN has defined the field of paediatric neurology and neurodisability and is one of the world’s leading journals in the whole field of paediatrics. DMCN disseminates a range of information worldwide to improve the lives of disabled children and their families. The high quality of published articles is maintained by expert review, including independent statistical assessment, before acceptance.